Day: March 2, 2020

Two Opportunities For Dancers – Rockettes Conservatory, A Three-Week Long Intensive, And Rockettes Preparatory, A One-Week Long Foundational – Both Begin This SummerPROGRAM DESIGNED TO IDENTIFY AND SUPPORT DEVELOPMENT OF POTENTIAL DANCERS FOR CELEBRATED DANCE COMPANYPROACTIVE, NATIONWIDE EFFORT TO FIND BEST TALENT BUILDS ON ROCKETTES COMMITMENT TO INCREASING INCLUSIVITY AND REPRESENTATION ON THE LINENEW YORK, March 02, 2020 (GLOBE NEWSWIRE) — The Radio City Rockettes today announced that it is investing in its future with the launch of a dedicated dancer development program designed to broaden the pipeline of potential Rockettes. Beginning this summer, there will be two distinct opportunities for dancers to receive the highest level of training dedicated to the precision technique of the world-famous Radio City Rockettes – Rockettes...

Á aðalfundi Festi hf. sem haldinn var þann 21. mars 2019 var samþykkt að heimila stjórn félagsins að kaupa á næstu 18 mánuðum hlutabréf í félaginu fyrir allt að 10% af heildarhlutafé félagsins í þeim tilgangi að að setja upp formlega endurkaupaáætlun eða til að gera hluthöfum almennt tilboð um kaup félagsins á eigin bréfum, t.d. með útboðsfyrirkomulagi, enda sé jafnræðis hluthafa gætt við boð um þátttöku í slíkum viðskiptum.Stjórn Festi hf. hefur á grundvelli fyrrgreindrar samþykktar tekið ákvörðun um framkvæmd endurkaupaáætlunar um kaup á eigin bréfum í þeim tilgangi að lækka útgefið hlutafé félagsins. Áætlunin mun hefjast þann 3. mars nk. Endurkaupin munu að hámarki nema 5.000.000 hlutum eða 1,5% af útgefnum hlutum í félaginu. Félagið á í dag 1.000.000 eigin hluti. Áætlunin er í gildi til 23. mars 2020, eða fram að aðalfundi félagsins...

At the Annual General Meeting of Festi hf. 21 March 2019 the shareholders decided to authorise the Board of Directors to execute a buy-back of up to 10% of own shares for a period of 18 months either by way of a buy-back programme or by a general offer to shareholders, including a tender arrangement, provided that equal treatment of shareholders was guaranteed.Having regard to the aforementioned authorisation, the Board of Directors of Festi has decided to execute a buy-back programme of own shares in order to reduce issued share capital. The programme will start on 3 March and covers a maximum of 5,000,000 shares or 1,5% of issued shares. The company holds 1,000,000 shares today. The duration of the programme is until 23 March 2020 or at the date of the Annual General Meeting 2020.Íslenskir fjárfestar hf. have been engaged to execute...

KELSEYVILLE, CA, March 02, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Vet Online Supply, Inc. (OTC PINK:VTNL) (“BrewBilt Manufacturing” or the “Company”), announces today 5 new orders of approximately $2M this week.Jef Lewis, CEO, stated, “Since the company went public, we are receiving new orders almost daily. We are working with 5 new locations; 1) Incline Village – Lake Tahoe,  2) Paso Robles-California, 3) Hong Kong, 4) a restaurant chain in Virginia and 5) a brewing company in Ohio. We have manufacturing to complete with 2 Mini-CBD Coldwater Extraction Systems and 6 orders on the production floor in order to make room for the new orders. There is a large order in Oakland-California that is next in line for completion.”BrewBilt Video Link: https://www.brewbilt.com/about-1ABOUT BREWBILT:  (www.brewbilt.com)Located in the...

 Dato: 2. marts 2020 Nasdaq OMX Copenhagen A/S Nikolaj Plads 6 1007 København K 　 Fondsbørsmeddelelse nr. 4/2020 　 Formanden for bankens repræsentantskab Hans Ladekjær Jeppesen bød velkommen til de fremmødte aktionærer. Efter velkomsten gav formanden ordet til den af bankens repræsentantskab udpegede dirigent advokat Bo Ascanius. Dirigenten konstaterede indledningsvis, at de fornødne indkaldelsesvarsler havde været iagttaget, samt at indkaldelsen, oplysning om antal aktier og stemmerettigheder, dagsorden, bankens lønpolitik, de fuldstændige forslag herunder revideret årsrapport, procedure for stemmeafgivelse samt fuldmagts- og brevstemmeblanket, i en sammenhængende periode på 3 uger havde været tilgængelig på bankens hjemmeside. Dagsordenens punkt 1 og 2: Bestyrelsens formand Hans Ladekjær Jeppesen aflagde bestyrelsens beretning om bankens...

GN Store Nord A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord A/S made by persons discharging managerial responsibilities in GN Store Nord A/S and/or persons closely related with them.For further information, please contact:Investors and analystsMorten P. ToftVice President – Investor Relations & TreasuryTel: +45 45 75 46 07OrRune SandagerSenior Manager – Investor Relations Tel: +45 45 75 92 57The GN Group is a global leader in intelligent audio solutions that let you hear more, do more and be more than you ever thought possible. Our ambitious 150-year journey has taken us from telegraph cables to radio waves and intelligent audio engineering. To celebrate our anniversary, we look to our unique competences within medical, professional...

JOHNS CREEK, Ga., March 02, 2020 (GLOBE NEWSWIRE) — Following audio as well as technical problems experienced during today’s Q4 2019 investor call, Ebix, Inc. (NASDAQ: EBIX) has posted management’s introductory prepared remarks, as well as a new audio recording of the CEO’s commentary on the investor section of its website (https://ebix.com/result_19_q4). Ebix apologizes for the technical problems this morning and is posting these materials to ensure investors have clear access to the comments. Ebix will post the full conference call transcript, including the Q&A session, on its website later today, along with the conference call audio, using the rerecorded CEO remarks.About Ebix, Inc.With 50+ offices across 6 continents, Ebix, Inc., (NASDAQ: EBIX) endeavors to provide On-Demand software and E-commerce services to the insurance,...

SHANGHAI, China, March 02, 2020 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd. (“the Company,” HKEX: 1877), an innovation-driven biopharmaceutical company dedicated to the discovery and development of innovative drugs with clinical research and commercialization on a global scale, today reported key financial results for the year 2019. The disclosure of the unaudited results is in relation to the Company’s reply to enquiry in respect of the application for IPO of A shares on the Science and Technology Innovation Board of the Shanghai Stock Exchange.  Please refer to the Company’s website for the announcements made on March 2, 2020, which contain additional information and disclosures regarding the financial results for the year 2019. Official annual results will be released in late March.KEY FINANCIAL INFORMATION...